{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:41:04Z","timestamp":1783122064111,"version":"3.54.6"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Uppsala-Orebro Regional Research Council","award":["RFR-30790"],"award-info":[{"award-number":["RFR-30790"]}]},{"name":"regional Research committee of Orebro lan","award":["OLL-259611"],"award-info":[{"award-number":["OLL-259611"]}]},{"name":"regional Research committee of Orebro lan","award":["OLL-459691"],"award-info":[{"award-number":["OLL-459691"]}]},{"name":"regional Research committee of Orebro lan","award":["OLL-671751"],"award-info":[{"award-number":["OLL-671751"]}]},{"DOI":"10.13039\/501100011777","name":"Scandinavian Society for Antimicrobial Chemotherapy Foundation","doi-asserted-by":"crossref","award":["SLS-171941"],"award-info":[{"award-number":["SLS-171941"]}],"id":[{"id":"10.13039\/501100011777","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.tmaid.2017.12.004","type":"journal-article","created":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T19:16:38Z","timestamp":1512760598000},"page":"43-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["An extra priming dose of hepatitis A vaccine to adult patients with rheumatoid arthritis and drug induced immunosuppression \u2013 A prospective, open-label, multi-center study"],"prefix":"10.1016","volume":"21","author":[{"given":"Anja","family":"Rosdahl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Fr\u00f6sner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torbj\u00f6rn","family":"Nor\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Rombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena H.","family":"Askling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3 Suppl","key":"10.1016\/j.tmaid.2017.12.004_bib1","first-page":"S32","article-title":"The impact of rheumatoid arthritis and treatment on patients' lives","volume":"28","author":"Strand","year":"2010","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.tmaid.2017.12.004_bib2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.autrev.2012.10.020","article-title":"Different effects of biological drugs in rheumatoid arthritis","volume":"12","author":"Atzeni","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.tmaid.2017.12.004_bib3","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.4269\/ajtmh.15-0185","article-title":"Immunocompromised travelers: demographic characteristics, travel destinations, and pretravel health care from the U.S. Global TravEpiNet consortium","volume":"93","author":"Schwartz","year":"2015","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.tmaid.2017.12.004_bib4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.tmaid.2016.03.008","article-title":"HAV & HBV vaccination among travellers participating in the National Health and Wellness Survey in five European countries","volume":"14","author":"Pedersini","year":"2016","journal-title":"Travel Med Infect Dis"},{"issue":"4","key":"10.1016\/j.tmaid.2017.12.004_bib5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1708-8305.2009.00307.x","article-title":"Hepatitis A risk in travelers","volume":"16","author":"Askling","year":"2009","journal-title":"J Travel Med"},{"issue":"1","key":"10.1016\/j.tmaid.2017.12.004_bib6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jinf.2008.10.010","article-title":"Hepatitis A among Danish travellers 1980-2007","volume":"58","author":"Nielsen","year":"2009","journal-title":"J Infect"},{"issue":"50","key":"10.1016\/j.tmaid.2017.12.004_bib7","doi-asserted-by":"crossref","first-page":"20992","DOI":"10.2807\/1560-7917.ES2014.19.50.20992","article-title":"Foodborne hepatitis A outbreak associated with bakery products in northern Germany, 2012","volume":"19","author":"Harries","year":"2014","journal-title":"Euro Surveill"},{"issue":"3","key":"10.1016\/j.tmaid.2017.12.004_bib8","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1086\/338152","article-title":"Influence of human immunodeficiency virus type 1 infection on acute hepatitis A virus infection","volume":"34","author":"Ida","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"8 Pt 2","key":"10.1016\/j.tmaid.2017.12.004_bib9","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1093\/clinchem\/43.8.1494","article-title":"Type A viral hepatitis: epidemiology, diagnosis, and prevention","volume":"43","author":"Lemon","year":"1997","journal-title":"Clin Chem"},{"issue":"8","key":"10.1016\/j.tmaid.2017.12.004_bib10","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/00007611-200295080-00010","article-title":"Hepatitis A epidemic in the elderly","volume":"95","author":"Brown","year":"2002","journal-title":"South Med J"},{"issue":"3","key":"10.1016\/j.tmaid.2017.12.004_bib11","first-page":"213","article-title":"Guidelines for the control of hepatitis A virus infection","volume":"4","author":"Crowcroft","year":"2001","journal-title":"Commun Dis Public Health"},{"issue":"2","key":"10.1016\/j.tmaid.2017.12.004_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.7326\/0003-4819-128-2-199801150-00006","article-title":"Serious hepatitis A: an analysis of patients hospitalized during an urban epidemic in the United States","volume":"128","author":"Willner","year":"1998","journal-title":"Ann Intern Med"},{"issue":"17","key":"10.1016\/j.tmaid.2017.12.004_bib13","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa070546","article-title":"Hepatitis A vaccine versus immune globulin for postexposure prophylaxis","volume":"357","author":"Victor","year":"2007","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.tmaid.2017.12.004_bib14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s100960100461","article-title":"Control of a community-wide outbreak of hepatitis A by mass vaccination with inactivated hepatitis A vaccine","volume":"20","author":"Zamir","year":"2001","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"41","key":"10.1016\/j.tmaid.2017.12.004_bib15","first-page":"1080","article-title":"Update: prevention of hepatitis a after exposure to hepatitis a virus and in international travelers. Updated recommendations of the advisory committee on immunization practices (ACIP)","volume":"56","author":"Novak","year":"2007","journal-title":"Morb Mortal Wkly Rep"},{"issue":"7","key":"10.1016\/j.tmaid.2017.12.004_bib16","article-title":"Hepatitis A immunisation in persons not previously exposed to hepatitis A","author":"Irving","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.tmaid.2017.12.004_bib17","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/infdis\/jiv060","article-title":"Response to hepatitis a vaccination in immunocompromised travelers","volume":"212","author":"Garcia Garrido","year":"2015","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.tmaid.2017.12.004_bib18","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1086\/315125","article-title":"Immunogenicity and safety of hepatitis A vaccine in liver and renal transplant recipients","volume":"180","author":"Stark","year":"1999","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.tmaid.2017.12.004_bib19","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/00007890-200107270-00019","article-title":"Safety and efficacy of hepatitis A vaccination in liver transplantation recipients","volume":"72","author":"Arslan","year":"2001","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.tmaid.2017.12.004_bib20","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/jtm.12050","article-title":"Seroprotection after hepatitis a vaccination in patients with drug-induced immunosuppression","volume":"20","author":"van den Bijllaardt","year":"2013","journal-title":"J Travel Med"},{"issue":"2","key":"10.1016\/j.tmaid.2017.12.004_bib21","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.tmaid.2014.01.005","article-title":"Hepatitis A vaccine for immunosuppressed patients with rheumatoid arthritis: a prospective, open-label, multi-centre study","volume":"12","author":"Askling","year":"2014","journal-title":"Travel Med Infect Dis"},{"issue":"1","key":"10.1016\/j.tmaid.2017.12.004_bib22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/01.MIB.0000437736.91712.a1","article-title":"Efficacy of hepatitis A vaccination and factors impacting on seroconversion in patients with inflammatory bowel disease","volume":"20","author":"Park","year":"2014","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.tmaid.2017.12.004_bib23","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00007890-200102150-00023","article-title":"Rapid decline of antibodies after hepatitis A immunization in liver and renal transplant recipients","volume":"71","author":"Gunther","year":"2001","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.tmaid.2017.12.004_bib24","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1002\/hep.26210","article-title":"Comparative effectiveness of two doses versus three doses of hepatitis A vaccine in human immunodeficiency virus-infected and -uninfected men who have sex with men","volume":"57","author":"Tseng","year":"2013","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.tmaid.2017.12.004_bib25","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/QAI.0b013e318183a9c0","article-title":"Immunological efficacy of a three-dose schedule of hepatitis A vaccine in HIV-infected adults: HEPAVAC study","volume":"49","author":"Launay","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"10.1016\/j.tmaid.2017.12.004_bib26","first-page":"606","article-title":"Long-term durability of responses to 2 or 3 doses of hepatitis A vaccination in HIV-positive adults on antiretroviral therapy","volume":"215","author":"Cheng","year":"2017","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.tmaid.2017.12.004_bib27","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.tmaid.2005.10.002","article-title":"Hepatitis A vaccines and the elderly","volume":"4","author":"Genton","year":"2006","journal-title":"Travel Med Infect Dis"},{"issue":"19","key":"10.1016\/j.tmaid.2017.12.004_bib28","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1016\/j.vaccine.2004.11.024","article-title":"Interchangeability and tolerability of a virosomal and an aluminum-adsorbed hepatitis A vaccine","volume":"23","author":"Bovier","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2017.12.004_bib29","series-title":"VassarStats: wibesite for statistical computation","year":"1998"},{"issue":"19\u201320","key":"10.1016\/j.tmaid.2017.12.004_bib30","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1016\/S0264-410X(02)00153-6","article-title":"Long term (24 months) follow-up of a hepatitis A and B vaccine, comparing a two and three dose schedule in adolescents aged 12-15 years","volume":"20","author":"Levie","year":"2002","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.tmaid.2017.12.004_bib31","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/cid\/ciw855","article-title":"Two doses of inactivated influenza vaccine improve immune response in solid organ transplant recipients: results of TRANSGRIPE 1-2, a randomized controlled clinical trial","volume":"64","author":"Cordero","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.tmaid.2017.12.004_bib32","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/1096-9071(200104)63:4<293::AID-JMV1004>3.0.CO;2-C","article-title":"Randomized controlled trial of seroresponses to double dose and booster influenza vaccination in frail elderly subjects","volume":"63","author":"Roos-Van Eijndhoven","year":"2001","journal-title":"J Med Virol"},{"issue":"7","key":"10.1016\/j.tmaid.2017.12.004_bib33","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJMoa1315727","article-title":"Efficacy of high-dose versus standard-dose influenza vaccine in older adults","volume":"371","author":"DiazGranados","year":"2014","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.tmaid.2017.12.004_bib34","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1086\/599790","article-title":"Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older","volume":"200","author":"Falsey","year":"2009","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.tmaid.2017.12.004_bib35","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1708-8305.2006.00001.x","article-title":"Immunogenicity and safety of a virosomal hepatitis A vaccine (Epaxal) in the elderly","volume":"13","author":"D'Acremont","year":"2006","journal-title":"J Travel Med"},{"issue":"6","key":"10.1016\/j.tmaid.2017.12.004_bib36","first-page":"408","article-title":"Sex and gender impact immune responses to vaccines among the elderly","volume":"30","author":"Fink","year":"2015","journal-title":"Physiol (Bethesda)"},{"issue":"2","key":"10.1016\/j.tmaid.2017.12.004_bib37","article-title":"Immunoglobulins for preventing hepatitis A","author":"Liu","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.tmaid.2017.12.004_bib38","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0016-5085(79)80030-X","article-title":"Immunoprophylaxis of viral hepatitis","volume":"77","author":"Seeff","year":"1979","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.tmaid.2017.12.004_bib39","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/clinids\/14.2.580","article-title":"Immunoglobulin prophylaxis for hepatitis A","volume":"14","author":"Winokur","year":"1992","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.tmaid.2017.12.004_bib40","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3109\/00365528109181012","article-title":"Clinical and subclinical hepatitis A occurring after immunoglobulin prophylaxis among Swedish UN soldiers in Sinai","volume":"16","author":"Weiland","year":"1981","journal-title":"Scand J Gastroenterol"},{"issue":"Suppl 1","key":"10.1016\/j.tmaid.2017.12.004_bib41","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/0264-410X(93)90151-M","article-title":"Single and booster dose responses to an inactivated hepatitis A virus vaccine: comparison with immune serum globulin prophylaxis","volume":"11","author":"Shouval","year":"1993","journal-title":"Vaccine"}],"updated-by":[{"DOI":"10.1016\/j.tmaid.2018.09.008","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000}}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893917302211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893917302211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:02:47Z","timestamp":1761487367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477893917302211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":41,"alternative-id":["S1477893917302211"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2017.12.004","relation":{},"ISSN":["1477-8939"],"issn-type":[{"value":"1477-8939","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An extra priming dose of hepatitis A vaccine to adult patients with rheumatoid arthritis and drug induced immunosuppression \u2013 A prospective, open-label, multi-center study","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2017.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}